Lineage-specific modulation of calcium pump expression during myeloid differentiation

Blood

Volumn 93, Issue 12, 1999, Pages 4395-4405

  Launay, Sophie ^b   Giannì, Maurizio ^b   Kovàcs, Tünde ^b   Bredoux, Raymonde ^b   Bruel, Ariette ^b   Gélébart, Pascal ^b   Zassadowski, Fabien ^b   Chomienne, Christine ^b   Enouf, Jocelyne ^b   Papp, Béla ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM; CYCLIC AMP; DEXAMETHASONE; PHORBOL ESTER; RETINOIC ACID; RETINOIC ACID RECEPTOR;

APOPTOSIS; ARTICLE; BONE MARROW CELL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; CELL MATURATION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; IMMUNOMODULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0033564923     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.12.4395.412k06_4395_4405     Document Type: Article

References (91)

1. Moller JV, Juul B, le Maire M: Structural organization, ion transport, and energy transduction of P-type ATPases. Biochim Biophys Acta 1286:1, 1996
2. Berridge MJ: Inositol trisphosphate and calcium signalling. Nature 361:315, 1993
3. Clapham DE: Calcium signaling. Cell 80:259, 1995
4. 2+ store: A view from the lumen. Trends Biochem Sci 23:10, 1998
5. 1-antitrypsin processing and transport competence. Biochem J 325:601, 1997
6. Wileman T, Kane LP, Carson GR, Terhorst C: Depletion of cellular calcium accelerates protein degradation in the endoplasmic reticulum. J Biol Chem 266:4500, 1991
7. Sei Y, Reich H: Thapsigargin induces IL-2 receptor alpha-chain in human peripheral and Jurkat T cells via a protein kinase C-independent mechanism. Immunol Lett 45:75, 1995
8. i-increasing agents cyclopiazonic acid and thapsigargin. J Biol Chem 269:8786, 1994
9. Gill DL, Waldron RT, Rys-Sikora KE, Ufret-Vincenty CA, Graber MN, Favre CJ, Alfonso A: Calcium pools, calcium entry, and cell growth. Biosci Rep 16:139, 1996
10. Wei H, Wei W, Bredesen DE, Perry DC: Bcl-2 protects against apoptosis in neuronal cell line caused by thapsigargin-induced depletion of intracellular calcium stores. J Neurochem 70:2305, 1998
11. 2+ stores in induction and suppression of apoptosis in S49 cells. Am J Physiol 272:C1241, 1997
12. Zhu WH, Loh TT: Differential effects of phorbol ester on apoptosis in HL-60 promyelocytic leukemia cells. Biochem Pharmacol 51:1229, 1996
13. Zhu H, Fearnhead HO, Cohen GM: An ICE-like protease is a common mediator of apoptosis induced by diverse stimuli in human monocytic THP-1 cells. FEBS Lett 374:303, 1995
14. Zhu WH, Loh TT: Roles of calcium in the regulation of apoptosis in HL-60 promyelocytic leukemia cells. Life Sci 57:2091, 1995
15. McConkey DJ, Orrenius S: The role of calcium in the regulation of apoptosis. Biochem Biophys Res Commun 239:357, 1997
16. Papp B, Byrn RA: Stimulation of HIV expression by intracellular calcium pump inhibition. J Biol Chem 270:10278, 1995
17. Kuo TH, Kim H-RC, Zhu L, Yu Y, Lin H-M, Tsang W: Modulation of endoplasmic reticulum calcium pump by Bcl-2. Oncogene 17:1903, 1998
18. 2+ATPase of sarcoplasmic reticulum. Expression in developing skeletal muscle. J Biol Chem 262:3768, 1987
19. 2+-ATPase gene. J Biol Chem 263:15024, 1988
20. 2+ and other cation-transporting ATPases using an oligonucleotide probe derived from the ATP-binding site. J Biol Chem 263:15032, 1988
21. Papp B, Enyedi A, Pàszty K, Kovàcs T, Sarkadi B, Gàrdos G, Magnier C, Wuytack F, Enouf J: Simultaneous presence of two distinct endoplasmic-reticulum-type calcium-pump isoforms in human cells. Biochem J 288:297, 1992
22. 2+-ATPaSe proteins. Biochem J 318:359, 1996
23. 2+ATPaSe (SERCA 3) in platelets. Possible recognition of the SERCA 3b isoform by the PL/IM430 monoclonal antibody. FEBS Lett 423:259, 1998
24. 2+ pump. J Biol Chem 264:18561, 1989
25. Lytton J, Poch E, Leach S, Lloyd S, Winkfein R, Yang W. Cloning and characterization of human SERCA 3. Biophys J 74:A359, 1998 (abstr)
26. 2+-ATPase 3 gene. J Biol Chem 273:13982, 1998
27. Papp B, Pàszty K, Kovàcs T, Sarkadi B, Gàrdos G, Enouf J, Enyedi A: Characterization of the inositol trisphosphate-sensitive and insensitive calcium stores by selective inhibition of the endoplasmic reticulum-type calcium pump isoforms in isolated platelet membrane vesicles. Cell Calcium 14:531, 1993
28. Davies EV, Hallett MB, Campbell AK: Localized superoxide release by neutrophils can be provoked by a cytosolic calcium 'cloud'. Immunology 73:228, 1991
29. Levy R, Rotrosen D, Nagauker O, Leto TL, Malech HL: Induction of the respiratory burst in HL-60 cells. J Immunol 145:2595, 1990
30. 2+ concentrations are essential and synergize with a kinetically distinct second signal. Biochem J 322:709, 1997
31. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, Berger R: NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 77:1080, 1991
32. Breitman TR, Sclonick SE, Collins SJ: Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 77:2936, 1980
33. Tarella C, Ferrero D, Gallo E, Pagliardi GL, Ruscetti FW: Induction of differentiation of HL-60 cells by dimethyl sulfoxide: Evidence for a stochastic model not linked to the cell division cycle. Cancer Res 42:445, 1982
34. Chen A, Licht JD, Wu Y, Hellinger N, Scher W, Waxman S: Retinoic acid is required for and potentiates differentiation of acute promyelocytic leukemia cells by nonretinoid agents. Blood 84:2122, 1994
35. Collins SJ, Robertson KA, Mueller L: Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-alpha). Mol Cell Biol 10:2154, 1990
36. Degos L, Parkinson DR (eds): Retinoids in Oncology. Berlin, Germany, Springer Verlag, 1995
37. Mangelsdorf DJ, Ong ES, Dyck JA, Evans RM: Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 345:224, 1990
38. Giguere V, Ong ES, Segui P, Evans RM: Identification of a receptor for the morphogen retinoic acid. Nature 330:624, 1987
39. Brand N, Petkovich M, Krust A, Chambon P, de Thé H, Marchio A, Tiollais P, Dejean A: Identification of a second human retinoic acid receptor. Nature 332:850, 1988
40. Levin AA, Sturzenbecker LJ, Kazmer S, Bosakowski T, Huselton C, Allenby G, Speck J, Kratzeisen CL, Rosenberger M, Loevy A, Grippo JF: 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα. Nature 355:359, 1992
41. de Thé H, Marchio A, Tiollais P, Dejean A: Differential expression and ligand regulation of the retinoic acid receptor α and β genes. EMBO J 8:429, 1989
42. Giannì M, Li Calzi M, Terao M, Guiso G, Caccia S, Barbui T, Rambaldi A, Garattini E: AM580, a stable benzole derivative of retinoic acid, has powerful and selective cyto-differentiating effects on acute promyelocytic leukemia cells. Blood 87:1520, 1996
43. Perez A, Kastner P, Sethi S, Lutz Y, Reibel C, Chambon P: PML/RAR homodimers: distinct DNA-binding properties and heteromeric interactions with RXR. EMBO J 12:3171, 1993
44. Chomienne C, Fenaux P, Degos L: Retinoid differentiation therapy in promyelocytic leukemia. FASEB J 10:1025, 1996
45. Mandelli F, Diverio D, Avvisati G, Luciano A, Barbui T, Bernasconi C, Broccia G, Cerri R, Falda M, Fioritoni G, Leoni F, Liso V, Petti MC, Rodeghiero F, Saglio G, Vegna ML, Visani G, Jehn U, Willemze R, Muus P, Pelicci PG, Biondi A, Lo Coco F: Molecular remission in PML/RARα-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Blood 90:1014, 1997
46. Warrell RP Jr: Retinoid resistance in acute promyelocytic leukemia: New mechanisms, strategies, and implications. Blood 82: 1949, 1993
47. Delva L, Comic M, Balitrand N, Guidez F, Micléa J-M, Delmer A, Teiltet F, Fenaux P, Castaigne S, Degos L, Chomienne C: Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells. Blood 82:2175, 1993
48. Macfarlane DE, Manzel L: Activation of β-isozyme of protein kinase C (PKCβ) is necessary and sufficient for phorbol ester-induced differentiation of HL-60 promyelocytes. J Biol Chem 269:4327, 1994
49. Rovera G, Santoli D, Damsky C: Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester. Proc Natl Acad Sci USA 76:2779, 1979
50. Nockher WA, Scherberich JE: Expression and release of the monocyte lipopolysaccharide receptor antigen CD 14 are suppressed by glucccorticoids in vivo and in vitro. J Immunol 158:1345, 1997
51. Rinehart JJ, Wuest D, Ackerman GA: Corticosteroid alteration of human monocyte to macrophage differentiation. J Immunol 129:1436, 1982
52. Chambers SK, Gilmore-Hebert M, Wang Y, Rodov S, Benz EJ Jr, Kacinski BM: Posttranscriptional regulation of colony-stimulating factor-1 (CSF-1) and CSF-1 receptor gene expression during inhibition of phorbol-ester-induced monocytic differentiation by dexamethasone and cyclosporin A: Potential involvement of a destabilizing protein. Exp Hematol 21:1328, 1993
53. Li Y-P, Said F, Gallagher RE: Retinoic acid-resistant HL-60 cells exclusively contain mutant retinoic acid receptor-α. Blood 83:3298, 1994
54. Bruel A, Benoit G, De Nay D, Brown, S, Lanotte M: Distinct apoptotic responses in maturation sensitive and resistant t(15;17) acute promyelocytic leukemia NB4 cells. 9-cis retinoic acid induces apoptosis independent of maturation and Bcl-2 expression. Leukemia 9:1173, 1995
55. Duprez E, Ruchaud S, Houge G, Martin-Thouvenin V, Valensi F, Kastner Ph, Berger R, Lanotte M: A retinoid acid 'resistant' t(15;17) acute promyelocytic leukemia cell line: Isolation, morphological, immunological and molecular features. Leukemia 6:1281, 1992
56. Duprez E, Lillehaug JR, Gaub MP, Lanotte M: Differential changes of retinoid-X-receptor (RXR alpha) and its RAR alpha and PML-RAR alpha partners induced by retinoic acid and cAMP distinguish maturation sensitive and resistant t(15;17) promyelocytic leukemia NB4 cells. Oncogene 12:2443, 1996
57. Gallagher R, Collins S, Trujillo J, McCredie K, Ahearn M, Tsai S, Metzgar R, Aulakh G, Ting R, Ruscetti F, Gallo R: Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood 54:713, 1979
58. Miller WH Jr, Jakubowski A, Tong WP, Miller VA, Rigas JR, Benedetti F, Gill GM, Truglia JA, Ulm E, Shirley M, Warrel RP Jr: 9-cis retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia. Blood 85:3021, 1995
59. Castaigne S, Balitrand N, de Thé H, Dejean A, Degos L, Chomienne C: A PML/retinoic acid receptor a fusion transcript is constantly detected by RNA-based polymerase chain reaction in acute promyelocytic leukemia. Blood 79:3110, 1992
60. Launay S, Bobe R, Lacabaratz-Porret C, Bredoux R, Kovàcs T, Enouf J, Papp B: Modulation of endoplasmic reticulum calcium pump expression during T lymphocyte activation. J Biol Chem 272:10746, 1997
61. Don RH, Cox PT, Wainwright BJ, Baker I, Mattick JS: 'Touch-down' PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res 19:4008, 1991
62. Tso JY, Sun XH, Kao TH, Reece KS, Wu R: Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: Genomic complexity molecular evolution of the gene. Nucleic Acids Res 13:2485, 1985
63. Lytton J, Westlin M, Burk SE, Shull GE, MacLennan DH: Functional comparisons between isoforms of the sarcoplasmic or endoplasmic reticulum family of calcium pumps. J Biol Chem 267: 14483, 1992
64. 2+-ATPase. Biochem J 250:355, 1988
65. Robertson KA, Mueller L, Collins SJ: Retinoic acid receptors in myeloid leukemia: Characterization of receptors in retinoic acid-resistant K-562 cells. Blood 77:340, 1991
66. Bissonnette RP, Brunner T, Lazarchik SB, Yoo NJ, Boehm MF, Green DR, Heyrnan RA: 9-cis retinoic acid inhibition of activation-induced apoptosis is mediated via regulation of Fas ligand and requires retinoic acid receptor and retinoid X receptor activation. Mol Cell Biol 15:5576, 1995
67. Yoshimura H, Nagai M, Hibi S, Kikuchi K, Abe S, Hida T, Higashi S, Hishinuma I, Yamanaka T: A novel type of retinoic acid receptor antagonist: Synthesis and structure-activity relationships of heterocyclic ring-containing benzoic acid derivatives. J Med Chem 38:3163, 1995
68. Chen J-Y, Clifford J, Zusi C, Starren J, Tortolani D, Ostrowski J, Reczek PR, Chambon P, Gronemeyer H: Two distinct actions of retinoid-receptor ligands. Nature 382:819, 1996
69. Apfel C, Bauer F, Crettaz M, Forni L, Kamber M, Kaufmann F, LeMotte P, Pirson W, Klaus M: A retinoic acid receptor a antagonist selectively counteracts retinoic acid effects. Proc Natl Acad Sci USA 89:7129, 1992
70. Zeiner M, Gehring U: Glucocorticoid receptor expression during differentiation of human promyeloic leukemia cells. Cancer Res 53:3513, 1993
71. Subramanian K, Meyer T: Calcium-induced restructuring of nuclear envelope and endoplasmic reticulum calcium stores. Cell 89:963, 1997
72. 2+ stores by cytochalasins. Exp Cell Res 234:379, 1997
73. 2+ stores in sarcoplasmic and endoplasmic reticulum. Science 275:1643, 1997
74. 2+) subcompartments in intact HeLa cells. J Cell Biol 139:601, 1997
75. 2+ATPaSe system in human platelets. Br J Haematol 97:192, 1997
76. 2+-ATPase. J Biol Chem 270:21050, 1995
77. 2+ stores in platelets, as identified by their differential sensitivity to 2,5-di-(tert-butyl)-1,4-benzohydroquinone and thapsigargin. Biochem J 310:449, 1995
78. He H, Lam M, McCormick TS, Distelhorst CW: Maintenance of calcium homeostasis in the endoplasmic reticulum by Bcl-2. J Cell Biol 138:1219, 1997
79. 2+ pumps. Biosci Rep 15:299, 1995
80. 2+ fluxes. Biochem J 281:325, 1992
81. Bradford PG, Wang X, Jin W, Hui P: Transcriptional regulation and increased functional expression of the inositol trisphosphate receptor in retinoic acid-treated HL-60 cells. J Biol Chem 267:20959, 1992
82. Aviram A, Rephaeli A, Shaklai M: The role of increased calcium influx rate in receptor mediated function of differentiating HL-60 cells. Cell Calcium 11:269, 1990
83. 2+ oscillations. Science 279:227, 1998
84. 2+ transients. J Biol Chem 269:27310, 1994
85. Dolmetsch RE, Xu K, Lewis RS: Calcium oscillations increase the efficiency and specificity of gene expression. Nature 392:933, 1998
86. 2+ spike frequency can optimize gene expression. Nature 392:936, 1998
87. 2+ response amplitude and duration. Nature 386:855, 1997
88. Berridge MJ: Calcium oscillations. J Biol Chem 265:9583, 1990
89. 2+ oscillations. Am J Physiol 269:C1079, 1995
90. 2+ excitability of the endoplasmic reticulum. Mol Biol Cell 6:945, 1995
91. Miyazaki S: Inositol trisphosphate receptor mediated spatiotemporal calcium signalling. Curr Opin Cell Biol 7:190, 1995